| Financial Year |
March 31 2023 |
| Monetary Funds |
2,001,557,818.80 |
| Held-for-trading Financial Assets |
139,891,955.92 |
| Notes Receivable |
-- |
| Accounts Receivable |
69,663,135.78 |
| Advances to Suppliers |
14,558,417.51 |
| Other Receivables |
124,607,753.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
171,285,078.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
75,871,634.81 |
| Total Current Assets |
2,597,435,794.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
26,713,919.64 |
| Long-term Equity Investment |
9,028,418.30 |
| Investment Properties |
4,273,501.06 |
| Fixed Assetes |
1,541,654,446.58 |
| Under-construction Projects |
11,955,910.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
234,472,883.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
178,141,206.80 |
| Deferred Income Tax Assets |
175,086,731.24 |
| Other Non-Current Assets |
840,869,300.01 |
| Sub-Total of Non-Current Assets |
5,218,276,395.12 |
| Total Assets |
7,815,712,189.86 |
| Short-Term Loans |
240,258,805.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
415,673,428.70 |
| Accounts Received In Advance |
16,261,062.23 |
| Employee Compensation Payable |
61,357,287.87 |
| Taxes Payable |
26,176,858.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,213,494,800.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
199,642,614.09 |
| Other Current Liabilities |
70,471,997.21 |
| Sub-Total of Current Liabilities |
2,389,410,002.81 |
| Long-term Loans |
-- |
| Bonds Payable |
995,495,790.05 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,975,338,318.81 |
| Total Liabilities |
4,364,748,321.62 |
| Paid-In Capital(Or Share Stock) |
798,736,665.00 |
| Capital Surplus |
1,979,666,246.11 |
| Surplus Reserve |
175,146,615.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
455,677,533.26 |
| Minority Stockholder's Interest |
23,541,882.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,427,421,986.05 |
| Owner's Equity（Stockholder's Equity） |
3,450,963,868.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,815,712,189.86 |
